Emma Guttman-Yassky
Icahn School of Medicine at Mount Sinai
H-index: 97
North America-United States
Top articles of Emma Guttman-Yassky
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Regulatory T-cell dysfunction and cutaneous exposure to Staphylococcus aureus underlie eczema in DOCK8 deficiency | Journal of Allergy and Clinical Immunology | Hazel Wilkie Mrinmoy Das Tyler Pelovitz Wayne Bainter Brian Woods | 2024/1/5 |
Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy | Journal of the American Academy of Dermatology | Cristina Faldetta Shaniko Kaleci Johanna Chester Cristel Ruini Silvana Ciardo | 2024/2/1 |
The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council | Journal of the European Academy of Dermatology and Venereology: JEADV | Robert Bissonnette Eric Simpson Lawrence F Eichenfield Emma Guttman-Yassky Jonathan I Silverberg | 2024/3 |
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201 … | Journal of Allergy and Clinical Immunology | Jonathan I Silverberg Bruce Strober Brian Feinstein Jinhua Xu Emma Guttman-Yassky | 2023/12/28 |
Die translationale Revolution bei der atopischen Dermatitis: Der Paradigmenwechsel von der Pathogenese zur Behandlung | Kompass Dermatologie | Paola Facheris Jane Jeffery Ester Del Duca Emma Guttman-Yassky | 2024/4/19 |
CLA+ memory T cells in atopic dermatitis: CLA+ T cells and atopic dermatitis | Lídia Sans‐de San Nicolàs Tali Czarnowicki Mübeccel Akdis Ramon M Pujol Daniel Lozano‐Ojalvo | 2024/1 | |
A Review of Atomic Force Microscopy in Skin Barrier Function Assessment | J Pereda C Milde Khatib S Kezic M Oberländer Christensen S Yang | 2024 | |
Targeting type 2 immune activation beyond atopic dermatitis | Annals of Allergy, Asthma & Immunology | Donald YM Leung Paola Facheris Karen A Veverka Ferda Cevikbas Emma Guttman-Yassky | 2024/2/1 |
Association between alopecia areata and atopic dermatitis: A nested case-control study of the All of Us database | Journal of the American Academy of Dermatology | Michael J Diaz Zaim Haq Parsa Abdi Jasmine T Tran Emma Guttman-Yassky | 2024/3/1 |
Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa | Journal of the American Academy of Dermatology | Kristina Navrazhina Yael Renert-Yuval Saakshi Khattri Hassan Hamade Marguerite Meariman | 2024/4/1 |
Pemphigoid and atopy: A case-control study in the All of Us database | The Journal of Allergy and Clinical Immunology: In Practice | Camille M Powers Austin J Piontkowski Brandon Block Jeremy Orloff Emma Guttman-Yassky | 2024/4/6 |
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape‐strips and biopsies | Allergy | Ester Del Duca Helen He Ying Liu Angel D Pagan Eden David | 2024/1 |
Integrated safety analysis of abrocitinib in 3802 patients with moderate-to-severe atopic dermatitis with over 5000 patientyears of exposure | ALLERGY AND ASTHMA PROCEEDINGS | Eric L Simpson Jonathan I Silverberg Audrey Nosbaum Kevin Winthrop Emma Guttman-Yassky | 2024/1/1 |
COVID-19 symptoms are attenuated in atopic dermatitis patients treated with dupilumab Short running title: Reduced COVID-19 symptoms in dupilumab-treated AD | Benjamin Ungar Jacob W Glickman Alexandra Golant Celina Dubin Olga Marushchak | 2024/1/31 | |
Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease Exhibits Activation of T Helper 1 and OX40 Cytokines | Journal of Investigative Dermatology | Madeline Kim Yael Renert-Yuval Polina Stepensky Ehud Even-Or Irina Zaidman | 2024/3/1 |
Targeting IL‐13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years | Allergy | Emma Guttman‐Yassky Kenji Kabashima Delphine Staumont‐Salle Walter K Nahm Sylvia Pauser | 2024/4/2 |
Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study | Allergy | Robert Bissonnette Janet DuBois Paola Facheris Ester Del Duca Madeline Kim | 2024/4 |
The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study | JAAD Case Reports | Jade N Young Hannah Verma Nour El Kashlan Dina Poplausky Angela J Lamb | 2024/1/1 |
OX40 in the Pathogenesis of Atopic Dermatitis—A New Therapeutic Target | Michael Croft Ehsanollah Esfandiari Camilla Chong Hailing Hsu Kenji Kabashima | 2024/1/18 | |
Transcriptomic evaluation of skin tape‐strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma‐associated biomarkers abnormalities | Allergy | Ester Del Duca Dante Dahabreh Madeline Kim Jonathan Bar Joel Correa Da Rosa | 2024/2/20 |
